Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 80, n° 6
pages 1796-1798 (juin 2019)
Doi : 10.1016/j.jaad.2019.02.014
Research Letters

A comparison of apremilast monotherapy and combination therapy for psoriatic arthritis in a real-life setting: Data from the Leeds Combined Psoriatic Service

Giuseppina Abignano, MD, PhD a, b, c, , Nafisa Fadl, MRCP a, b, Mira Merashli, MD a, b, Claire Vandevelde, MRCP, MD a, b, Jane Freeston, MRCP, MD a, b, Dennis McGonagle, FRCPI, PhD a, b, Helena Marzo-Ortega, LMS, MRCP, PhD a, b
a National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom 
b Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom 
c Rheumatology Institute of Lucania, Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera, Potenza, Italy 

Reprint requests: Giuseppina Abignano, MD, PhD, Rheumatology Institute of Lucania, Rheumatology Department of Lucania, San Carlo Hospital, Via Potito Petrone snc, 85100 Potenza, ItalyRheumatology Institute of LucaniaRheumatology Department of LucaniaSan Carlo HospitalVia Potito Petrone sncPotenza85100Italy

 Funding sources: Supported by the National Institute for Health Research Leeds Biomedical Research Centre.
 Conflicts of interest: Dr Marzo-Ortega has received grants and honoraria from AbbVie, Celgene, Janssen, Lilly, Novartis, Pfizer, and UCB. Dr Abignano has received honoraria from Celgene. Prof McGonagle has received grants and honoraria from Celgene. Dr Fadl, Dr Merashli, Dr Vandevelde, and Dr Freeston have no conflicts of interest to disclose.
 Disclaimer: The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.

Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline